<VariationArchive RecordType="classified" VariationID="1459025" VariationName="NC_000001.10:g.(?_68895449)_(68915598_?)del" VariationType="Deletion" Accession="VCV001459025" Version="4" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-11" DateCreated="2022-03-28" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1406154" VariationID="1459025">
      <GeneList>
        <Gene Symbol="RPE65" FullName="retinoid isomerohydrolase RPE65" GeneID="6121" HGNC_ID="HGNC:10294" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p31.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="68428822" stop="68449954" display_start="68428822" display_stop="68449954" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="68894506" stop="68915641" display_start="68894506" display_stop="68915641" Strand="-" />
          </Location>
          <OMIM>180069</OMIM>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NC_000001.10:g.(?_68895449)_(68915598_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p31.3-31.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" innerStart="68895449" innerStop="68915598" display_start="68895449" display_stop="68915598" variantLength="20150" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.(?_68895449)_(68915598_?)del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.(?_68895449)_(68915598_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000001.10:g.(?_68895449)_(68915598_?)del AND multiple conditions" Accession="RCV001975124" Version="4">
        <ClassifiedConditionList TraitSetID="9541">
          <ClassifiedCondition DB="MedGen" ID="C1859844">Leber congenital amaurosis 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C3151086">Retinitis pigmentosa 20</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-07" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18632300</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9326941</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9501220</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9843205</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9541" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5384" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Amaurosis congenita of Leber, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AMAUROSIS CONGENITA OF LEBER II</ElementValue>
                <XRef Type="MIM" ID="204100" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">RPE65-Related Leber Congenital Amaurosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Leber congenital amaurosis 2</ElementValue>
                <XRef ID="Leber+congenital+amaurosis+type+2/4136" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008765" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LCA2</ElementValue>
                <XRef Type="MIM" ID="204100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000501118" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000553865" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500417" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506299" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000518813" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000502495" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">RPE65-related Leber congenital amaurosis / early-onset severe retinal dystrophy (RPE65-LCA/EOSRD) is a severe inherited retinal degeneration (IRD) with a typical presentation between birth and age five years. While central vision varies, the hallmark of this disorder is the presence of severe visual impairment with a deceptively preserved retinal structure. Vision is relatively stable in the first decade of life, but begins to decline in adolescence. Most affected individuals are legally blind (visual acuity 20/200 and/or visual fields extending &lt;20 degrees from fixation) by age 20 years. After age 20 years, visual acuity declines further and by the fourth decade all affected individuals are legally blind and many have complete loss of vision (i.e., no light perception). Milder disease phenotypes have been described in individuals with hypomorphic alleles.</Attribute>
                <XRef ID="NBK549574" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="636" />
                <XRef ID="636" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">30285347</ID>
                <ID Source="BookShelf">NBK531510</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31725251</ID>
                <ID Source="BookShelf">NBK549574</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="65" DB="Orphanet" />
              <XRef ID="C1859844" DB="MedGen" />
              <XRef ID="MONDO:0008765" DB="MONDO" />
              <XRef Type="MIM" ID="204100" DB="OMIM" />
            </Trait>
            <Trait ID="6587" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Retinitis pigmentosa 20</ElementValue>
                <XRef ID="Retinitis+Pigmentosa+20/6259" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013425" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">RP 20</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RP20</ElementValue>
                <XRef Type="MIM" ID="613794" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10404" />
                <XRef ID="10404" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301590</ID>
                <ID Source="BookShelf">NBK1417</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="791" DB="Orphanet" />
              <XRef ID="C3151086" DB="MedGen" />
              <XRef ID="MONDO:0013425" DB="MONDO" />
              <XRef Type="MIM" ID="613794" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4261115" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_000329.2_Deletion (Entire Coding Sequence)|MedGen:C1859844;C3151086" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002240371" DateUpdated="2023-11-11" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9326941</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9501220</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9843205</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18632300</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the RPE65 gene has been identified. Loss-of-function variants in RPE65 are known to be pathogenic (PMID: 9326941, 9501220, 9843205, 18632300). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. This variant has not been reported in the literature in individuals affected with RPE65-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RPE65" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.(?_68895449)_(68915598_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1859844" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3151086" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4261115" TraitType="Disease" MappingType="XRef" MappingValue="C1859844" MappingRef="MedGen">
        <MedGen CUI="C1859844" Name="Leber congenital amaurosis 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4261115" TraitType="Disease" MappingType="XRef" MappingValue="C3151086" MappingRef="MedGen">
        <MedGen CUI="C3151086" Name="Retinitis pigmentosa 20" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

